BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 189424)

  • 1. [Bone-marrow biopsy in chronic myeloid leukemia. Value of the initial examination].
    Devred C; Bentata J; Diebold J; Bernadou A; Bilski-Pasquier G
    Sem Hop; 1977 Jan; 53(2):119-24. PubMed ID: 189424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bone-marrow biopsy in chronic myeloid leukemia. Significance during development].
    Devred C; Bentata J; Diebold J; Bernadou A; Bilski-Pasquier G
    Sem Hop; 1977 Jan; 53(2):125-31. PubMed ID: 189425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Jamshidi biopsy in clinical hematology. Method, indications and results of over 1,000 completed biopsies with special reference to chronic myeloproliferative diseases].
    Seewann HL
    Wien Med Wochenschr Suppl; 1986; 100():1-24. PubMed ID: 3471009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
    Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression.
    Panteli K; Zagorianakou N; Bai M; Katsaraki A; Agnantis NJ; Bourantas K
    Eur J Haematol; 2004 Jun; 72(6):410-5. PubMed ID: 15128419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bone marrow biopsy in myeloproliferative syndromes: prognostic value of cellular quantification].
    Esquivias López-Cuervo JJ; Romero Aguilar A; González García J
    Sangre (Barc); 1990 Apr; 35(2):98-101. PubMed ID: 2363101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The value of the initial bone biopsy in chronic myeloproliferative syndromes. Review of 80 cases].
    Ortuño F; Zuazu I; Bordes R; Brunet S; Puig J; Ayats R
    Sangre (Barc); 1989 Apr; 34(2):117-25. PubMed ID: 2667169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Emperipolesis in megakaryocytes in patients with thrombocytosis in the course of myeloproliferative disorders].
    Bobik R; Podolak-Dawidziak M; Kiełbiński M; Jeleń M; Wróbel T
    Acta Haematol Pol; 1995; 26(2):179-83. PubMed ID: 7653223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of bone marrow biopsy in chronic myeloid leukaemia.
    Seewann HL; Lehnert M; Jüttner F
    Haematologia (Budap); 1983; 16(1-4):67-72. PubMed ID: 6592124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of chronic myeloproliferative diseases based on bone marrow biopsy].
    Matolcsy A; Kónya T; Wéber E
    Orv Hetil; 1992 Jun; 133(26):1617-20, 1625-6. PubMed ID: 1614699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelofibrosis in the myeloproliferative disorders.
    Ellis JT; Peterson P
    Prog Clin Biol Res; 1984; 154():19-42. PubMed ID: 6382293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow biopsy in chronic myeloid leukemia: significance of some histological parameters.
    Lambertenghi-Deliliers G; Pozzoli E; Benazzi E; Maiolo AT; Foa P; Polli E
    Haematologica; 1986; 71(2):113-6. PubMed ID: 3087831
    [No Abstract]   [Full Text] [Related]  

  • 14. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
    Thiele J; Kvasnicka HM; Beelen DW; Flucke U; Spoer C; Paperno S; Leder LD; Schaefer UW
    Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence in situ hybridization reveals closely correlated results in cytological and histological specimens of hematological neoplasias compared to conventional cytogenetics.
    Gerr H; Gadzicki D; Kreipe H; Schlegelberger B; Wilkens L
    Pathobiology; 2006; 73(6):271-9. PubMed ID: 17374964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
    Macavei I; Galatâr N
    Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of bone marrow cytology in the diagnosis of leukosis in dogs].
    Moritz A; Grünbaum EG
    Tierarztl Prax; 1993 Jun; 21(3):243-51. PubMed ID: 8346528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.
    Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z
    Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic criteria for classification and differential diagnosis of chronic myeloproliferative disorders.
    Frisch B; Bartl R; Burkhardt R; Jäger K
    Haematologia (Budap); 1984; 17(2):209-26. PubMed ID: 6534829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.